Literature DB >> 22962681

Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO.

Tina L Sumpter1, Anil Dangi, Benjamin M Matta, Chao Huang, Donna B Stolz, Yoram Vodovotz, Angus W Thomson, Chandrashekhar R Gandhi.   

Abstract

Hepatic stellate cells (HSCs) are critical for hepatic wound repair and tissue remodeling. They also produce cytokines and chemokines that may contribute to the maintenance of hepatic immune homeostasis and the inherent tolerogenicity of the liver. The functional relationship between HSCs and the professional migratory APCs in the liver, that is, dendritic cells (DCs), has not been evaluated. In this article, we report that murine liver DCs colocalize with HSCs in vivo under normal, steady-state conditions, and cluster with HSCs in vitro. In vitro, HSCs secrete high levels of DC chemoattractants, such as MΙP-1α and MCP-1, as well as cytokines that modulate DC activation, including TNF-α, IL-6, and IL-1β. Culture of HSCs with conventional liver myeloid (m) DCs resulted in increased IL-6 and IL-10 secretion compared with that of either cell population alone. Coculture also resulted in enhanced expression of costimulatory (CD80, CD86) and coinhibitory (B7-H1) molecules on mDCs. HSC-induced mDC maturation required cell-cell contact and could be blocked, in part, by neutralizing MΙP-1α or MCP-1. HSC-induced mDC maturation was dependent on activation of STAT3 in mDCs and, in part, on HSC-secreted IL-6. Despite upregulation of costimulatory molecules, mDCs conditioned by HSCs demonstrated impaired ability to induce allogeneic T cell proliferation, which was independent of B7-H1, but dependent upon HSC-induced STAT3 activation and subsequent upregulation of IDO. In conclusion, by promoting IDO expression, HSCs may act as potent regulators of liver mDCs and function to maintain hepatic homeostasis and tolerogenicity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22962681      PMCID: PMC3466356          DOI: 10.4049/jimmunol.1200819

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  84 in total

Review 1.  The liver as a lymphoid organ.

Authors:  Ian Nicholas Crispe
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock.

Authors:  In Duk Jung; Min-Goo Lee; Jeong Hyun Chang; Jun Sik Lee; Young-Il Jeong; Chang-Min Lee; Won Sun Park; Jin Han; Su-Kil Seo; Sang Yong Lee; Yeong-Min Park
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

3.  Human liver dendritic cells promote T cell hyporesponsiveness.

Authors:  Zubin M Bamboat; Jennifer A Stableford; George Plitas; Bryan M Burt; Hoang M Nguyen; Alexander P Welles; Mithat Gonen; James W Young; Ronald P DeMatteo
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

4.  SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.

Authors:  Ciriana Orabona; Maria T Pallotta; Claudia Volpi; Francesca Fallarino; Carmine Vacca; Roberta Bianchi; Maria L Belladonna; Maria C Fioretti; Ursula Grohmann; Paolo Puccetti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

5.  Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion.

Authors:  Zubin M Bamboat; Lee M Ocuin; Vinod P Balachandran; Hebroon Obaid; George Plitas; Ronald P DeMatteo
Journal:  J Clin Invest       Date:  2010-01-19       Impact factor: 14.808

6.  Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans.

Authors:  P Bonifazi; T Zelante; C D'Angelo; A De Luca; S Moretti; S Bozza; K Perruccio; R G Iannitti; G Giovannini; C Volpi; F Fallarino; P Puccetti; L Romani
Journal:  Mucosal Immunol       Date:  2009-05-06       Impact factor: 7.313

7.  In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha.

Authors:  Michael K Connolly; Andrea S Bedrosian; Jon Mallen-St Clair; Aaron P Mitchell; Junaid Ibrahim; Andrea Stroud; H Leon Pachter; Dafna Bar-Sagi; Alan B Frey; George Miller
Journal:  J Clin Invest       Date:  2009-10-12       Impact factor: 14.808

8.  Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo.

Authors:  Naoki Iwamoto; Hiroyasu Ito; Kazuki Ando; Tetsuya Ishikawa; Akira Hara; Ayako Taguchi; Kuniaki Saito; Masao Takemura; Michio Imawari; Hisataka Moriwaki; Mitsuru Seishima
Journal:  Liver Int       Date:  2008-04-05       Impact factor: 5.828

9.  Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3.

Authors:  Yaping Sun; Y Eugene Chin; Elizabeth Weisiger; Chelsea Malter; Isao Tawara; Tomomi Toubai; Erin Gatza; Paolo Mascagni; Charles A Dinarello; Pavan Reddy
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

10.  The induction of APC with a distinct tolerogenic phenotype via contact-dependent STAT3 activation.

Authors:  Devorah Gur-Wahnon; Zipora Borovsky; Meir Liebergall; Jacob Rachmilewitz
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more
  35 in total

1.  Stellate Cells Orchestrate Concanavalin A-Induced Acute Liver Damage.

Authors:  Richa Rani; Ashish Tandon; Jiang Wang; Sudhir Kumar; Chandrashekhar R Gandhi
Journal:  Am J Pathol       Date:  2017-07-13       Impact factor: 4.307

2.  Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice.

Authors:  Ralph C Quillin; Gregory C Wilson; Hiroyuki Nojima; Christopher M Freeman; Jiang Wang; Rebecca M Schuster; John A Blanchard; Michael J Edwards; Chandrashekhar R Gandhi; Erich Gulbins; Alex B Lentsch
Journal:  Hepatol Res       Date:  2014-06-04       Impact factor: 4.288

Review 3.  Role of interleukin-6 in cachexia: therapeutic implications.

Authors:  Aditi A Narsale; James A Carson
Journal:  Curr Opin Support Palliat Care       Date:  2014-12       Impact factor: 2.302

4.  Hepatic stellate cells increase the immunosuppressive function of natural Foxp3+ regulatory T cells via IDO-induced AhR activation.

Authors:  Sudhir Kumar; Jiang Wang; Angus W Thomson; Chandrashekhar R Gandhi
Journal:  J Leukoc Biol       Date:  2016-08-31       Impact factor: 4.962

5.  New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.

Authors:  Min Hyeok Jee; Ka Young Hong; Ji Hoon Park; Jae Seung Lee; Hee Sun Kim; Song Hee Lee; Sung Key Jang
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 6.  The Tumor Microenvironment Innately Modulates Cancer Progression.

Authors:  Dominique C Hinshaw; Lalita A Shevde
Journal:  Cancer Res       Date:  2019-07-26       Impact factor: 12.701

Review 7.  Environmental peer pressure: CD4+ T cell help in tolerance and transplantation.

Authors:  Dana Tedesco; Arash Grakoui
Journal:  Liver Transpl       Date:  2018-01       Impact factor: 5.799

8.  DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance.

Authors:  O Yoshida; S Kimura; L Dou; B M Matta; S Yokota; M A Ross; D A Geller; A W Thomson
Journal:  Am J Transplant       Date:  2014-06-16       Impact factor: 8.086

Review 9.  O death where is thy sting? Immunologic tolerance to apoptotic self.

Authors:  Buvana Ravishankar; Tracy L McGaha
Journal:  Cell Mol Life Sci       Date:  2013-02-03       Impact factor: 9.261

10.  A novel mouse model of depletion of stellate cells clarifies their role in ischemia/reperfusion- and endotoxin-induced acute liver injury.

Authors:  Rachel K Stewart; Anil Dangi; Chao Huang; Noriko Murase; Shoko Kimura; Donna B Stolz; Gregory C Wilson; Alex B Lentsch; Chandrashekhar R Gandhi
Journal:  J Hepatol       Date:  2013-09-20       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.